Introduction {#sec1}
============

Cervical cancer is ranked the 7^th^ most common cancer in the world. Cervical cancer is the second most commonly diagnosed cancer after breast cancer and the third leading cause of cancer deaths among females in less developed countries. Incidence rates are highest in countries with low income. Nearly 90% of cervical cancer deaths occurred in developing parts of the world. The cervix is divided into two halves; the endo-cervix, which is made up of columnar epithelium and the exo-cervix made up of squamous epithelium. The two halves merge at the squamo-columnar junction (SCJ), an important zone for malignant transformation. The SCJ varies in position throughout the reproductive life of a woman with an outward trend into the vagina. Cervical dysplasia, precancerous lesions in the cervical transformation zone can lead to cervical cancer \[[@cit0001]\]. Cervical cancer is preventable and curable if early diagnosed. The causative agent of the disease is the Human Papilloma Virus (HPV) which is transmitted through sexual intercourse causing cervical cancer through a slow growth over a period of 10-20 years \[[@cit0001]\]. There are over 150 different types of HPV; more than 40 can infect the cervix and are sexually transmitted, causing 99.4% of cervical cancer cases and 100% of genital warts cases. Out of the 150 types, about a dozen are carcinogenic. HPV-16 accounts for 50% to 55% of all cases of invasive cervical cancer worldwide while HPV-18 accounts for an additional 10% to 15%. Highly Active Antiretroviral Therapy (HAART) and evolution of cervical disease causes a high prevalence of cervical cancer in Cameroon \[[@cit0002]\]. Strains 16 and 18 are known to be responsible for up to 70% of cervical cancer worldwide \[[@cit0003]\]. It has been proven that, at least 50% of women who are sexually active have suffered an infection with at least one strain of HPV \[[@cit0004]\]. The global incidence of cervical cancer is greater than 530 000 annually, with death approaching 275 000 per year \[[@cit0005]\]. The prevalence of cervical cancer worldwide is estimated by \[[@cit0006]\] to be 12%. One of the most important reasons for the incidence of cervical cancer in developing countries is the lack of early detection of pre-cancerous lesions and treatment of the lesions before they progress \[[@cit0007]\].

Among the newly diagnosed cases, 86% are reported in poor countries. Also, 88% of deaths resulting from cervical cancer are in the low-income countries \[[@cit0008]\]. In Africa, the incidence is 80 000 per annum, with an annual mortality of 75%; most of the cases are seen in sub-Saharan Africa \[[@cit0008]\]. It was shown that cervical cancer prevalence was up to 13.8%; this is based on a study carried out in the capital city Yaounde \[[@cit0009]\]. More than 6 million Cameroonian females who are aged 15 and above are at risk of developing cervical cancer, and there are 1993 new cases of cervical cancer yearly, of which 1120 die of the disease annually \[[@cit0003]\]. In poor countries, awareness as well as uptake of cervical cancer screening services has remained poor over the years. Several studies done in communities and among women in sub-Saharan Africa revealed that knowledge were generally poor \[[@cit0010]\]. Risk factors of cervical cancers have also been highly demonstrated among Cameroonian women, especially the rural women \[[@cit0011]\]. Mogtomo and colleagues \[[@cit0012]\] have demonstrated a high incidence of sexually transmissible infections, multiple sexual partners, low use of condoms and other risk factors of cervical cancer among students in the University of Douala \[[@cit0013]\]. This therefore, calls for relevant measures to reduce this trend of progression. With current and appropriate measures put in place to prevent cervical cancer, success of screening will largely depend on the awareness and beliefs among women. The knowledge level of the general population is very important in determining the right strategy in planning an effective intervention against cervical cancer. WHO \[[@cit0002]\] reported that cervical cancer screening coupled with immediate management leads to early detection of precancerous and cancerous cervical lesions, thus preventing serious morbidity and mortality due to the cervical cancer disease\' In a study carried out by \[[@cit0014]-[@cit0017]\], they demonstrated that the level of awareness of HPV infection and prevention of cervical cancer is moderately low in Cameroon. Gardasil for HPV 6 and 11, and Cervarix for HPV 16 and 18 are available in the market for cervical cancer \[[@cit0017]\].

Methods {#sec2}
=======

**Study design, setting and population:** The study was conducted in the Bamenda Regional Hospital, North West Region of the Republic of Cameroon. Bamenda is a city in North Western Cameroon and capital of the North West Region. The city has a population of about 500,000 people. Bamenda is situated at 5.95° North latitude, 10.16° East longitude and 1472 meters elevation above the sea level. In the cancer department where registration, screening and surgery for cancer are done is one of the 18 units of the Bamenda Regional Hospital. These units include, the Directorate and its Secretariat, Laboratory department, Day Care (which capture all HIV/AIDS, testing and treatment of cases), Diabetic/ Hypertensive unit, Ear, Nose and Throat Department, Dental Department, Out Patient Department, Social Service, Ostectric/Gynachologic, Theatre, General/Infant Consultation Department, Equipment Department, Sanitary Department, Mortuary, Palliative Care and the Obstetric/Gynecologic Department.

Selection criteria {#sec2.1}
------------------

**Inclusion criterion:** All women managed for cancer from 2012 to 2017 in the centre were included in the final analysis.

**Exclusion criterion:** All negative results.

**Sample size and sampling:** All patients\' records were checked.

**Data collection:** All patient\'s files were thoroughly checked and data on age, sex, type of cancer, type of surgery carried out and the year of surgery were captured into an excel template.

**Data analyses:** Data was entered into Excel, verified for completeness. Incomplete entries were deleted and cleaned before analyses. Descriptive data analysis in the form of tables, pie charts, and bar or column charts were used.

**Ethical considerations:** Ethical clearance was obtained from the Institutional Ethical Review Board of the Faculty of Health Sciences, University of Buea. Authorization to use the cancer registry was gotten from the Directorate of the Regional Hospital Bamenda who are the custodians of the cancer registry. Confidentiality and integrity of the data were maintained by restricting access of the information and primary data to the Principal Investigator.

Results {#sec3}
=======

**Availability of cancer data:** 59 cancer cases were received during the study period (2012 to 2017). [Figure 1](#f0001){ref-type="fig"} shows the proportions of the different cancer types in patients who consulted at the cancer centre of the Bamenda Regional Hospital.

![Proportions of different cancer types in patients consulting at the cancer registry of Bamenda Regional Hospital](PAMJ-32-90-g001){#f0001}

**Cancer types and types of surgery:** 6 different types of cancers (cervical cancer, breast cancer, endometrial cancer, adenocarcinoma of the colon, ovarian cell tumor and vulva carcinoma) were diagnosed within this period. Abdominal hysterectomy was the most common type of surgery done for all the cancers. The surgeries were carried out within the study period ([Table 1](#t0001){ref-type="table"}, [Figure 1](#f0001){ref-type="fig"}).

###### 

Cancer types, type of surgery and the year of surgery

  S/N   Age   Type of cancer                                                  Stage                                        Type of Surgery                                    Date of Surgery
  ----- ----- --------------------------------------------------------------- -------------------------------------------- -------------------------------------------------- ------------------
  1     31    Severe cervical displasia                                       CIN III(Cervical intraepithelial neoplasis   Total abdominal hysterectomy                       26/11/14
  2     44    Precancerous lesions of the cervix plus urinary incontinence    CIN III                                      TAH plus Burgs culpud suspension                   18/11/16
  3     42    Cervical neoplasia                                              Stage 1B2                                    Total abdominal hysterectomy                       09/12/14
  4     38    Severe cervical dysplasia                                       CIN III                                      Total abdominal hysterectomy                       13/12/14
  5     42    Endometrial carcinoma plus uterine fibroid                      Stage 1                                      Total abdominal hysterectomy                       06/01/15
  6     69    Cervical cancer                                                 Invasive cervical cancer stage 1B            Wertheims hysterectomy                             06/02/15
  7     43    Non keratinized moderaretly differentiated squamous carcinoma   Stage 1B                                     Wertheims hysterectomy                             20/12/16
  8           Cancer of cervix                                                Stage 2B                                     EUA                                                20/12/16
  9     53    Precancerous lesions of the cervix                              CIN III                                      laparatomy                                         27/03/15
  10    20    Ovarian tumor                                                   Stage 3                                      Exploratory laparatomy                             17/01/12
  11    40    Cervical cancer                                                 Cervical dysplasia CIN3                      HYSTERECTOMY                                       21/02/12
  12    40    Breast cancer                                                   T2NoMo                                       Radical left mastectomy                            21/04/16
  13    44    Breast cancer                                                   T2N1N0                                       Radical left mastectomy                            24/01/13
  14    69    Cervical cancer                                                 Carcinoma insitu                             Total abdominal hystrectomy                        24/10/12
  15    50    Breast cancer                                                   T2NoMo                                       mastectomy                                         13/03/13
  16    48    Cervical cancer                                                 Stage 1A                                     Total hysterectomy                                 02/06/16
  17    37    Breast cancer                                                   Intramedullary carcinoma of left breast      Left total mastectomy and axillary clearance       04/06/13
  18    37    Bilateral breast cancer                                         T3N2M2                                       Bilateral mastectomy and lymph                     10/08/16
  19    55    Cervical cancer                                                 Stage 1A                                     Total abdominal hysterectomy                       15/07/13
  20    60    Breast neoplasia                                                T2NoMo                                       Left total mastectomy                              24/09/13
  21    36    Breast cancer                                                   T2NoMo                                       Mastectomy plus axillary clearance                 14/11/13
  22    22    Lobular carcinoma                                               T4N1MO                                       Radical mastectomy                                 31/10/16
  23    51    Pre cervical cancer                                             CIN III                                      Total hysterectomy                                 09/11/16
  24    44    Vagina, vulva plus genital warts                                Stage2B                                      vulvectomy                                         \#\#\#\#\#\#\#\#
  25    54    Cervical cancer                                                 Stage 2B                                     Total abdominal hysterectomy                       \#\#\#\#\#\#\#\#
  26    34    Cervical cancer                                                 2A                                           Weitheim hysterectomy                              \#\#\#\#\#\#\#\#
  27    50    Cervical cancer                                                 1B                                           Weitheim hysterectomy                              \#\#\#\#\#\#\#\#
  28    54    Cervical cancer squamous cell carcinoma                         2B                                           Wertheim hysterectomy                              \#\#\#\#\#\#\#\#
  29    34    Cervical cancer                                                 4                                            Radio/chemo                                        \#\#\#\#\#\#\#\#
  30    58    Adenocarcinoma colon                                                                                         chemo                                              \#\#\#\#\#\#\#\#
  31    50    Cervical cancer                                                 4                                            Radio/chemo                                        \#\#\#\#\#\#\#\#
  32    33    Cervical Cancer                                                 4                                            quadrectomy                                        \#\#\#\#\#\#\#\#
  33    61    Cancer of cervix                                                4                                            Radio/chemo                                        \#\#\#\#\#\#\#\#
  34    52    Cervical cancer                                                 Stage 4                                      Radio/ chemo                                       Rip
  35    47    Cancer of the right breast                                      Stage 1                                      Quandrantectomy adenomectomy chemo, radiotherapy   \#\#\#\#\#\#\#\#
  36    46    CA of right breast invasive ducts carcinoma                     1B                                           Mastectomy plus lymphadencetomy                    \#\#\#\#\#\#\#\#
  37    43    Cervical cancer                                                 1B                                           TAH                                                \#\#\#\#\#\#\#\#
  38    62    Cervical cancer                                                 1B                                           TAH                                                \#\#\#\#\#\#\#\#
  39    23    Cancer of the right breast plus pregnacy                        T3NoMo                                       Lost to follow-up                                  \#\#\#\#\#\#\#\#
  40    44    Precancerous lesions of the cervix                              CIN2/CIN3                                    Total hysterectomy                                 05/01/17
  41    42    Suspected left ovarian tumor                                    Stage 2                                      Total abdominal hysterectomy +BSO                  20/01/17
  42    54    Epidermoid carcinoma                                            Stage 1B                                     Total hysterectomy, wertheims hysterectomy         31/01/16
  43    28    Left breast cancer                                              T2NoMo                                       Total left mastectomy                              08/02/17
  44    39    Cervical lesion suspected malignant                                                                          Total hysterectomy                                 27/01/17
  45    46    Cervical cancer                                                 CIN3                                         Weitheim hysterectomy                              31/07/16
  46    80    Endometrial hypeplasia in menopose                              Stage I                                      Total abdominall hysterectomy                      15/07/15
  47    56    Precancerous cervix                                             CIN III                                      Total hysterectomy                                 26/06/15
  48    68    Moderate cervical dysplasia                                     CIN II                                       Total hysterectomy                                 28/05/15
  49    63    Granulosa cell tumor                                            Stage 2                                      Dibulking surgery                                  \#\#\#\#\#\#\#\#
  50    52    Squamous cell carcinoma                                         Stage I A                                    Total abdominal Hysterectomy                       \#\#\#\#\#\#\#\#
  51    48    Breast cancer                                                   T2N0M0                                       mastectomy                                         \#\#\#\#\#\#\#\#
  52    70    Granulosa cells tumors                                          Stage 2                                      Debulking surgery                                  \#\#\#\#\#\#\#\#
  53    50    Ductal carcinoma                                                T3N0M1                                       TAH                                                \#\#\#\#\#\#\#\#
  54    62    Aderno carcinpoma                                               Stage 1B                                     TAH +Radio therapy                                 \#\#\#\#\#\#\#\#
  55    47    Breast cancer                                                   T2N                                          Mastectomy and radiotherapy                        \#\#\#\#\#\#\#\#
  56    36    Ductal carcinoma                                                T4N1M1                                       Ductal chemotherapy                                \#\#\#\#\#\#\#\#
  57    38    Breast lump                                                     T2N1Mx                                       mastectomy                                         \#\#\#\#\#\#\#\#
  58    70    Breast cancer                                                   T3N1Mx                                       mastectomy                                         \#\#\#\#\#\#\#\#
  59    40    Ductal carcinoma                                                T3N1Mx                                       mastectomy                                         \#\#\#\#\#\#\#\#

**Cervical cancer types and stages:** Cancer of cervix, cervical lesion, precancerous cervix, squamous cell carcinoma and cervical dysplasia were the types of cervical cancer, we found cancer of the cervix occuring the highest with 16 out of the 31 cases. Stage III was the most frequent stage of cervical cancer diagnosed ([Table 2](#t0002){ref-type="table"}). Cervical cancer ranked first in all cases reported during this period with 31(52%) cases ([Figure 2](#f0002){ref-type="fig"}).

###### 

Cervical cancer types and stages

  S/N   Age   Type of Cancer                                                 Stage
  ----- ----- -------------------------------------------------------------- --------------------------------------------
  1     31    Severe cervical displasia                                      CIN III(Cervical intraepithelial neoplasis
  2     44    Precancerous lesions of the cervix plus urinary incontinence   CIN III
  3     42    Cervical neoplasia                                             Stage 1B2
  4     38    Severe cervical dysplasia                                      CIN III
  5     69    Cervical cancer                                                Invasive cervical cancer stage 1B
  6     43    Non keratinized moderately differentiated squamous carcinoma   Stage 1B
  7     45    Cancer of cervix                                               Stage 2B
  8     53    Precancerous lesions of the cervix                             CIN III
  9     69    Cervical cancer                                                Carcinoma insitu
  10    40    Cervical cancer                                                Cervical dysplasia CIN3
  11    48    Cervical cancer                                                Stage 1A
  12    55    Cervical cancer                                                Stage 1A
  13    51    Pre-cervical cancer                                            CIN III
  14    34    Cervical cancer                                                2A
  15    50    Cervical cancer                                                1B
  16    54    Cervical cancer squamous cell carcinoma                        2B
  17    34    Cervical cancer                                                4
  18    50    Cervical cancer                                                4
  19    33    Cervical Cancer                                                4
  20    61    Cancer of cervix                                               4
  21    52    Cervical cancer                                                Stage 4
  22    43    Cervical cancer                                                1B
  23    62    Cervical cancer                                                1B
  24    39    Cervical lesion suspected malignant                            CNIII
  25    46    Cervical cancer                                                CIN3
  26    56    Precancerous cervix                                            CIN III
  27    68    Moderate cervical dysplasia                                    CIN II
  28    52    Squamous cell carcinoma                                        Stage I A
  29    36    Ductal carcinoma                                               T4N1M1
  30    44    Precancerous lesions of the cervix plus urinary incontinence   CIN III
  31    52    Squamous cell carcinoma                                        Stage I A

![Cervical cancer distribution in patients of various ages consulting at the cancer registry of Bamenda Regional hospital](PAMJ-32-90-g002){#f0002}

**Age distribution of cervical cancer:** The youngest patient was 31 years old while the oldest patient was 69 years. Most cases were between the ages of 50-54 years. The minimum age group of cervical cancer was 30-34years while the maximum was 65-69 years with the highest number of cervical cancer cases found in the 50-54 years age group ([Figure 2](#f0002){ref-type="fig"}).

Discussion {#sec4}
==========

Cancer of the cervix was the predominant type of cancer (52.2%) in the Bamenda Regional Hospital. This was far higher than 13.8% reported by \[[@cit0009]\] 2012 in Yaounde-Cameroon, and 29.9% reported by \[[@cit0017]\] 2013 in Yaounde-Cameroon. Their study results were derived from pathology results while ours was derived from surgery. It was also, different from a study conducted in 6 regions in Cameroon to determine the prevalence of cervical premalignant lesions from where; the national prevalence was 3.9% \[[@cit0015]\]. This difference could be due to the fact that, Tebeu and colleagues \[[@cit0015]\] had a larger sample size than our study and their study was representative. One of the most important reasons for the incidence of cervical cancer in developing countries is the lack of early detection of pre-cancerous lesions and treatment of the lesions before they progress \[[@cit0007]\].

Atashili and colleagues \[[@cit0016]\] also, reported a prevalence of 11.5% of SIL due to cervical disease in women receiving HAART in Cameroon. This was far lower than the 52% obtained in our study, it could however be different because our study was not limited to HIV/AIDS patients receiving HAART. Torre and colleagues \[[@cit0007]\] reported that cervical cancer is the second most commonly diagnosed cancer after breast cancer and the third leading cause of cancer deaths among females in less developed countries. From our study, cervical cancer ranked first, followed by breast cancer. This difference could be due to the fact that our study concentrated on just one region while that of Torre and colleagues \[[@cit0007]\] was carried out in several other regions. The highest age group with cervical cancer was 50-54; this is similar to the age at high risk of many types of cancer. Completeness of registration of cancer cases in this population was estimated at about 50%.

**Some limitations in our study includes:** Limited demographic information available for the women who were screened positive for cervical cancer; the fact that the researchers did not screen the women for cervical cancer but rather collected data from hospital records to determine the prevalence of cervical cancer is the reason for limited demographic information. Despite this shortcoming, this study provides relevant information in the context of very limited epidemiological data on the prevalence of cervical cancer among other types of cancers in the cancer registry of the Bamenda Regional Hospital, North West Region of Cameroon.

Conclusion {#sec5}
==========

The proportion of cervical cancer (52 %), among other types of cancers found in the cancer registry of the Bamenda Regional Hospital is high. The most affected group with cervical cancer was 50-54 year old group; which is similar to the age with a high risk to develop most cancers.

What is known about this topic {#sec5.1}
------------------------------

-   Cameroon in the year 2000, it revealed a prevalence of 7.9%, and the age of first intercourse as the major risk factor (the prevalence of cervical cancer in Cameroon in 2000 stood at 7.9%, which main risk factor being age at first sexual intercourse);

-   Cervical cancer is the second most commonly diagnosed cancer after breast cancer 80 000 per annum, with an annual mortality of 75%; with most of the cases are seen in sub-Saharan Africa;

-   More than 6 million Cameroonian females who are aged 15 and above are at risk of developing cervical cancer, and there are 1993 new cases of cervical cancer yearly, of which 1120 die of the disease annually.

What this study adds {#sec5.2}
--------------------

-   Over half (52%) of cancers managed in the Bamenda Regional Hospital are cervical cancers;

-   Most cancer patients seen are above 50 years of age;

-   Most cancer cases are referred late in the disease course.
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